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Abstract 
Here we study the self-assembly of arginine capped bolaamphiphile peptide RA3R 
(A: alanine, R: arginine) together with its binding to model membranes and RA3R cytotoxic 
and antimicrobial activities. Anionic 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-
glycerol) sodium salt/ 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine 
(POPG/POPE) vesicles and zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine/ 2-oleoyl-
1-palmitoyl-sn-glycero-3-phosphocholine (POPC/DOPC) vesicles are used as model 
membranes to mimic bacterial and mammalian cell membranes respectively. We show that 
RA3R adopts a polyproline II collagen-like conformation in water.  Binding of RA3R to 
POPG/POPE vesicles induces a strong correlation between the lipid bilayers, driven by 
RA3R/POPG attractive electrostatic interaction together with a shift of the intramolecular 
POPE zwitterionic interaction towards an attractive electrostatic interaction with the RA3R. 
Populations of RA3R/POPG/POPE vesicles comprise different bilayer spacings dA and dB, 
controlled by the conformation of the lipid chains corresponding to the L (gel-like) and L 
(liquid-crystal) phases respectively. Cryo-TEM images reveal the presence of vesicles with 
no internal structure, compartmentalized thin wall vesicles or multilayer vesicles with 
uncorrelated layers and compartmentalization, depending on the RA3R/POPG/POPE 
composition. In contrast, the interaction of RA3R with multilamellar POPC/DOPC vesicles 
leads to the de-correlation of the lipid bilayers. RA3R was tolerated by skin fibroblast cells for 
a concentration up to 0.01wt%, while 0.25 wt% RA3R probed to be an efficient antibacterial 
agent against Gram-positive bacteria L. monocytogenes. Our results highlight the ability of 
RA3R to distinguish between bacterial and mammalian cells and set this peptide as a 
candidate to reduce proliferation of L. monocytogenes bacteria.  
 
 
 
 
3 
 
Introduction 
The development of innovative antimicrobial agents is attracting great interest 
because of the major global healthcare challenge of emerging antimicrobial resistance 
(AMR) to currently available drugs. Antimicrobial peptides are an important class of 
antimicrobials since they have evolved naturally in many plants and organisms and these 
can be exploited directly, or used as a basis for biomimetic antimicrobial peptide 
development. 
A surfactant-like peptide (SLP) is conventionally considered to be a peptide 
comprising a short hydrophobic peptide sequence attached to a sequence of charged 
residues. This class of peptide was originally developed by S. Zhang et al. 1-4  Examples 
include peptides with hydrophobic glycine, valine or alanine repeats and charged 
headgroups (either cationic or anionic), for instance G8D2, H2V6, V6D2, A6K, A6D, etc. Our 
group has previously studied the self-assembly of A6K,5-6 A6H,7 A6R,8 A6RGD9 and A6D10 
among others. All these SLPs aggregate above defined critical aggregation concentrations 
(CACs). A6K forms nanotubes in concentrated aqueous solution.5-6, 11 A6H forms nanotapes, 
the morphology of which can be tuned using pH and ZnCl2 (which coordinates with the 
histidine residue).7 A6R self-assembly motif in aqueous solutions can be changed from 
nanosheets into helical ribbons and nanotubes upon increasing the concentration of the 
sample.8 A6RGD incorporates the RGD cell adhesion motif, and forms fibrils or vesicles in 
water as a function of the concentration.9 A6D self-assembles into nanosheets.10 
SLPs have remarkable self-assembly properties and a diversity of applications. For 
example, A6D can replace surfactants in the production of soluble G-protein coupled 
receptors using E. coli cell-free systems.12 A6D can potentially be used in drug delivery 
formulations, since the SLP forms nanovesicles at physiological conditions.13 However in 
another paper from the same group, nanotubes, or nanotubes with bulges (which also 
appear to be like bead aggregate structures) were reported under the same conditions.14 
Most relevant to the present paper, SLPs incorporating cationic head groups have been 
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shown to have antimicrobial activity. Recent work15 shows that although addition of A3K did 
not reduce the number of bacteria, A6K and A9K show antimicrobial activity against Gram-
negative E.coli and Gram-positive S. aureus.15 The antibacterial activity increases with 
increasing hydrophobicity, which also influences self-assembly since A3K forms ill-defined 
aggregates, whereas it was reported that A6K and A9K form elongated nanostructures.15 The 
peptide A6R shows antimicrobial activity against the same bacteria, however with greater 
activity against S. aureus.16 The interaction of this peptide with zwitterionic DPPC [1,2-
dipalmitoyl-sn-glycero-3-phosphocholine] lipid membranes was also investigated, and a lack 
of lysis with this type of membrane (of the same class as the membranes of eukaryotes) was 
noted.16 Peptide bolaamphiphiles (with charged residues at both ends) are another class of 
surfactant-like peptide. In particular, the self-assembly of SLPs including I2K2I2 and KI4K 
were investigated and the sequence change was found to profoundly influence aggregation 
since the former shows no defined nanostructure (and there is no evidence for -sheet 
formation) whereas the latter forms nanotubes based on -sheet hydrogen bonding.17-18 The 
self-assembly of arginine peptide bolaambolaamphiphile RFL4FR has been investigated and 
its compatibility with cells (fibroblasts) was demonstrated.19  
Here, we report on the self-assembly and antimicrobial activity of the novel SLP 
RA3R incorporating arginine residues at both termini. In this process, we also report the 
interaction of RA3R with lipid membranes representing the cell wall of bacteria (vesicles 
containing mixtures of POPG/POPE lipids) or animals (vesicles containing mixtures of 
DOPC/POPC lipids). POPG indicates 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-
glycerol) sodium salt, POPE denotes 2-oleoyl-1-palmitoyl-sn-glycero-3-
phosphoethanolamine, DOPC denotes 1,2-dioleoyl-sn-glycero-3-phosphocholine and POPC 
denotes 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine. Vesicle compositions are based 
on the knowledge that lipids from the phosphatidylethanolamine (PE) and 
phosphatidylglycerol (PG) classes are the most abundant lipids in the composition of 
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bacterial membranes 20 while POPC is the major lipid component of mammalian 
membranes.21 
Here we use a range of microscopy and spectroscopy techniques and small-angle X-
ray scattering (SAXS) to probe the assembly and conformation of RA3R in water and its 
interaction with model lipid membranes. Finally, we evaluate the cytotoxicity and 
antimicrobial activity of RA3R.     
 
Experimental 
Samples. Peptide RA3R was custom synthesized by Biomatik (UK). The peptide was 
received as a TFA salt, the purity was determined by the supplier to be 96.86% as 
determined from HPLC (0.1 % TFA in water/ acetonitrile gradient).  Mw= 543.63 Da was 
measured by electro-spray ionization mass spectroscopy (ESI-MS) analysis. Lipids POPG 
(Mw= 770.99 Da), POPE (Mw= 718 Da), DOPC (Mw= 786.11 Da) and POPC (Mw= 760.08 
Da) were purchased from Sigma Aldrich (UK) and used as received. RA3R is positively 
charged in water (+2). POPE, POPC and DOPC are zwitterionic in water. POPG is 
negatively charged in water (-1).  Scheme 1 displays the chemical structures for RA3R, 
POPE, POPC, DOPC and POPG. 
Vesicle preparation. Vesicles were prepared by the thin layer hydration method, used in 
previous studies on binary POPE/POPG vesicles.22 Weighted quantities of lipids were 
dissolved in chloroform. Thin films of lipids were obtained by drying the chloroform under a 
stream of nitrogen. Traces of the organic solvent were removed by placing the lipid films in a 
vacuum chamber for 2 hrs.   Lipid films were then re-suspended in a weighted quantity of 
water corresponding to 0.5 wt% lipid. Lipid solutions were vortexed for 5 minutes (1800 rpm; 
55 oC) and left to equilibrate before experiments. POPG/POPE anionic vesicles were made 
using mixtures of lipids at different molar ratios to provide POPG molar fractions POPG = 
[POPG]/([POPG]+[POPE]) = 1, 0.6, 0.5, 0.4, 0.2 and 0 ([ ]: molar concentration) which 
corresponds to a POPG/POPE % content (e.g, % POPE= 100xweight 
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POPE/weight(POPE+POPG)) of 100, 65/35, 50/50, 44/56, 27/73 and 0. Zwitterionic vesicles 
were made by mixing POPC and DOPC lipids at a molar ratio to provide a DOPC molar 
fraction DOPC= [DOPC]/([POPC]+[DOPC]) = 0.2 which corresponds to a POPC/DOPC % 
content of 80/20. Samples containing RA3R and lipids were made by adding a weighed 
quantity of RA3R powder to solutions of 0.5 wt% lipid vesicles, in order to obtain 0.08, 0.25 
or 0.5 wt% RA3R. The mixtures were then vortexed for 5 minutes (1800 rpm, 55 oC) and left 
to equilibrate before experiments.  
In the following we will omit the concentration of POPG/POPE and POPC/DOPC 
mixtures because it was kept at 0.5 wt% for all the samples. The composition of each 
sample will be indicated only by the relevant mole fraction of lipid (POPG or DOPC) and the 
concentration of RA3R in wt%. 
Circular Dichroism (CD) Spectroscopy. CD spectra were recorded using a Chirascan 
spectropolarimeter (Applied Photophysics, UK). Solutions were placed in a quartz cover slip 
cuvette (0.01 mm thick). Spectra were measured using a 0.5 nm step, 1 nm bandwidth, and 
1 s collection time per step. Only data with absorbance A < 2 was recorded during the 
experiments. The CD data is corrected by the CD signal from the water background. Where 
data has been smoothed, the smoothed spectra present no distortions in the residual trace. 
Fourier Transform Infra-Red (FTIR) Spectroscopy. FTIR data were recorded using a 
Nexus-FTIR spectrometer equipped with a DTGS detector. Solutions were measured using 
the PEARL liquid transmission accessory. Spectra were measured for wavenumbers in the 
range 900-4000 cm-1. Each spectrum was scanned 128 times. 
Small-Angle and X-Ray Scattering (SAXS). Synchrotron SAXS experiments were 
performed using BioSAXS robots on beamline BM29 (ESRF, France) and on beamline B21 
(Diamond Light Source Ltd., ESRF). On BM29 and B21, the solutions were manually loaded 
into the 96 well plate of an EMBL BioSAXS robot. The robot injected the solutions into a 
quartz capillary (1.8 mm internal diameter) placed in front of the X-ray beam. After the 
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sample was injected in the capillary and reached the X-ray beam, the flow was stopped for 
the acquisition of the SAXS data. The quartz capillary was enclosed in a vacuum chamber to 
avoid parasitic scattering. B21 operated with a 3.9 m camera length and 12.4 keV 
energy.  The images were captured using a Pilatus 2M detector. Data was corrected by 
background subtraction and then radially averaged, using the dedicated beamline software 
ScÅtter. BM29 operated with an X-ray wavelength  = 1.03 Å (12 keV).  The images were 
captured using a PILATUS 1M detector, while data processing was performed using 
dedicated beamline software ISPYB (BM29). 
Cryogenic Transmission Electron Microscopy (Cryo-TEM). Experiments were carried out 
using a field emission cryo-electron microscope (JEOL JEM-3200FSC) operating at 300 kV. 
Images were taken using bright-field mode and zero loss energy filtering (omega type) with a 
slit with 20 eV. Micrographs were recorded using a Gatan Ultrascan 4000 CCD camera. The 
specimen temperature was maintained at -187 °C during the imaging. Vitrified specimens 
were prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 holey carbon 
copper grids with 3.5 μm hole sizes. Grids were cleaned using a Gatan Solarus 9500 plasma 
cleaner just prior to use and then transferred into an environmental chamber of FEI Vitrobot 
at room temperature and 100% humidity. Thereafter, 3 μl of sample solution with 0.5 wt% 
concentration was applied on the grid, blotted once for 1 second and then vitrified in a 1/1 
mixture of liquid ethane and propane at -180 °C. Grids with vitrified sample solutions were 
maintained in a liquid nitrogen atmosphere and then cryo-transferred into the microscope.  
Cell Viability assays. The cytotoxicity of RA3R was examined. In vitro cell culture was 
conducted using the 161br (ECACC) human skin fibroblast cell line. Cells were cultured in 
EMEM, with 2 mM glutamine, enriched with 15% fetal bovine serum (FBS), 1% non-essential 
amino acids (NEAA) and 1% antibiotic-antimycotic (100x). Cells were maintained in a 
humidified atmosphere of 5% CO2 at 37oC.  Cytotoxicity was examined using the MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. RA3R was dissolved in 
complete medium. Cells were seeded into a 96-well plate at a seeding density of 4 x 104 
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cells/mL, and allowed to adhere for 24 hours in 100 µL complete medium. After 24 hours, a 
total volume of 100 µL of either complete medium and/or peptide solution was added, to give 
final peptide concentrations of 0.5, 0.25, 0.1, 0.05, 0.01 or 0.005 wt% RA3R. After 67 hours 
of incubation, 20 µL of MTT (5 mg/mL in PBS) was added to each well plate and allowed to 
incubate for 5 hours (total of 72 hours incubation). After this, the solution was removed from 
each well and replaced with 100 µL DMSO per well in order to dissolve the formazan 
crystals. Plates were incubated for 30 minutes, and then analysed using a UV microplate 
reader (λ = 570 nm). Results are reported as a percentage cell viability compared to control 
(untreated values).  The ANOVA and Bonferoni post hoc tests were used to check statistical 
significance.  
Bacterial strains and growth conditions. Experiments were performed with three different 
microorganisms namely, Staphylococcus aureus, Listeria monocytogenes and Escherichia 
coli. The strains used were a wild type strain of Staphylococcus aureus previously isolated 
from ham23 a widely-used wild type strain of L. monocytogenes (LO28;24-25) and one of the 
most widely-used E. coli strains (K-12). Stock cultures were stored at -80 °C in 7% (vol/vol) 
DMSO (Sigma-Aldrich, Dorset, UK). Prior to experiments, stock cultures of S. aureus and L. 
monocytogenes were streaked onto brain heart infusion (BHI) agar (LAB M, Lancashire, UK) 
while those of E. coli were streaked onto Lysogeny Broth (LB) agar (Oxoid, UK) and 
incubated overnight at 37 °C.  
Preparation of cell suspension. Three colonies from these cultures were then transferred 
to 3 ml sterile Tryptone soy broth (TSB) supplemented with 0.3%(w/v) yeast extract (TSBY) 
(Oxoid, UK) and grown at 37 °C under agitation at 150 rev min-1 on a Gallenkamp orbital 
shaker for 24 h. Subsequently, 20 ml of TSB broth was inoculated with the previously 
prepared overnight cultures up to 1% and grown at 37 °C under agitation at 150 rev min-1 for 
a further 24 hours. These cultures were used for the subsequent experiments.  
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The viability of the cultures was assessed before use by serially diluting in Maximum 
Recovery Diluent (MRD, Oxoid) and plating onto nutrient agar. Cultures were transferred into 
50 ml falcon tubes (VWR UK) and cells were harvested by centrifugation at 9000 rpm and 4 
°C, for 10 min in an Eppendorf 5804 centrifuge. The supernatant was then discarded and the 
pellet was re-suspended in 1.5 mL ice chilled PBS. Twenty μl of this solution was then 
transferred into 200 μl of RA3A peptide solution (0.25 wt%) which had been prepared in 
sterile water.  Control solutions were made by inoculating 200 μl of sterile water with 20 μl of 
the PBS suspended culture. Solutions were then vortexed for 3 seconds and samples taken 
at 0, 30, 60, 120 and 1440 min. 100 μl of the peptide culture solution was then serially 
diluted in MRD and subsequently 10 μl of each dilution was plated onto plate count agar 
(PCA) and incubated at 37 °C for 24 hours before the enumeration of colonies.  
 
Results and Discussion 
We first examined the self-assembly of RA3R in water. CD, FTIR and SAXS data are 
shown in Figure 1.  
The CD spectra for 0.08-0.5 wt% RA3R show a deep minimum at 190 nm along with 
a broad positive maximum at around 220 nm (Figure 1a); a signature of polyproline II 
(collagen-like) secondary structure.26-34 This structure has been observed for other short 
polyalanine peptides.32  
FTIR spectra for 2, 0.5, 0.25 and 0.08 wt% RA3R show bands at 1672, 1587 and 
1608 cm-1 (Figure 1b). The peak at 1672 cm-1 is due to bound TFA counterions.35-37 FTIR 
bands at 1587 and 1608 cm-1 are related to vibrational bands associated with the side 
chains of the R-residues.38-39 In addition, the 2 wt% RA3R sample shows a FTIR band at 
1675 cm-1, which consistent with the CD spectra, is characteristic of short polyalanine 
peptides with a PPII structure.40-41  
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Figure 1c shows the SAXS data for 0.5 and 10 wt% RA3R. The SAXS data for 0.08 
and 0.25 wt% RA3R had very poor statistics and therefore has not been included in the 
manuscript. Since the SAXS data for 0.5 wt% RA3R is relatively weak, the SAXS data for 10 
wt% RA3R has been included in Figure 1c as a reference. SAXS data for 0.5 and 10 wt% 
RA3R (Figure 1c) was modelled according to a Gaussian coil model using the SASfit 
program.42-43 The parameters of this model are the radius of gyration of the Gaussian chain 
Rg and the excluded volume parameter . The fitted models provided Rg= 4.8, 8.9 Å and = 
0.43, 0.6 for 10 and 0.5 wt% RA3R respectively. The excluded volume parameter  indicates 
a swollen conformation of the peptide chain at 0.5 wt% RA3R, and a relatively folded 
conformation of the peptide chain at 10 wt% RA3R. Cryo-TEM on 1 wt% RA3R did not show 
the formation of any nanostructure (results not shown). 
These results indicate that RA3R does not self-assemble in water, probably due to 
the high solubility due to the two terminal R residues and the flexibility of PPII structure. 
Therefore, in the following we will focus on the interaction of RA3R with model anionic and 
zwitterionic membranes.  
Table S1 lists the POPG/POPE + RA3R mixtures studied in this work along with the 
appearance of the solutions. POPG/POPE vesicles with POPG= 1, 0.6, 0.5, 0.4, 0.2 or 0 were 
mixed with 0, 0.08, 0.25 or 0.5 wt% RA3R. In this way, the influence of the lipid composition 
in mixtures at a given peptide concentration was examined while additionally the influence of 
peptide concentration was probed. Table S1 shows that homogeneous cloudy samples were 
obtained for  POPG= 1, 0.6, 0.5, 0.4, 0.2 or 0 + 0 wt% RA3R, for POPG= 1, 0.6, 0.5, 0.4 or 0.2 
+ 0.08 wt% RA3R and for POPG= 0.6, 0.5, 0.4 or 0.2 + 0.25 wt% RA3R. But phase separation 
(sample precipitation) was observed for other samples.  
Figure 2 shows the SAXS data measured for samples in Table S1. Spacings d, 
measured from the position of the peaks in the SAXS data (d= 2/q0; q0= position of the 
peak maximum), are displayed in Figure 2. Table 1 shows representative examples, as a 
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function of  POPG, for the indexation of the spacings d displayed in Figure 2. SAXS data  in 
Figure 2 for samples with POPG= 1, 0.6 or 0.4 + 0.5 wt% RA3R is dominated by the scattering 
from the precipitate, as cryo-TEM results later in the text show that there are no vesicles in 
the supernatant. 
We first consider the SAXS profiles of the lipid mixtures without added peptide. The 
SAXS data in Figure 2 was measured at 20 oC. A previous SAXS study of POPG/POPE 
vesicles shows that at 20 oC, samples with POPG= 0 are in the L (gel-solid ordered phase) 
phase, samples with POPG= 0.2 are at the L/L (fluid disordered liquid crystal phase) phase 
co-existence point, and samples with 0.4≤ POPG ≤ 1 are in the L phase.22 Here, we 
measured a lamellar spacing of 61.6 Å for POPG= 0 in the L (gel) phase (Table 1), in good 
agreement with data in the literature.22 SAXS for  0.2≤ POPG ≤ 1 shows a broad peak centred 
at q~0.1 Å-1, which was previously ascribed to MLVs (with walls consisting of freely 
fluctuating and uncorrelated bilayers) for 0.4 ≤ POPG <1, but to unilamellar vesicles for 
POPG= 1 (the negative charge of the lipids leads to a net electrostatic repulsion of the 
bilayers).22  
Figures 2a-e shows that addition of RA3R to samples with  POPG= 1, 0.6, 0.5, 0.4 and 
0.2 induces a strong correlation between bilayers, corresponding to a lamellar order denoted 
by the presence of scattering peaks in the SAXS curves. Noticeably, increasing the peptide 
concentration does not alter the position of the scattering peaks for a fixed POPG, but it can 
increase the order of the reflexions in the SAXS pattern (e.g. Figure 2a-c).  The RA3R 
induced bilayer order is divided in two populations with lamellar cell parameter dA or dB, 
which increases from 70.9 to 72.9 Å and from 59.3 to 63.7 Å respectively, for POPG 
fractions decreasing from 1 to 0.2 (Figure 2, Table 1). In contrast, the addition of RA3R to 
samples containing POPG= 0 (100% POPE) does not induce any order different from the 
lamellar spacing at 61.6 Å measured at 0 wt% RA3R (Figure 2f, Table 1).  
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The SAXS data in Figure 2 was fitted using models for the form factor and structure factor 
of lamellar structures, in an attempt to get a closer insight into the nanostructure of the 
solutions. Details of the model44 are provided in the Supplementary Information. We only 
fitted the data for the samples in Figure 2c, containing POPG= 0.5 and 0-0.5 wt% RA3R, as a 
representative result for the data plotted in Figure 2 with 1 ≤ POPG< 0. Fits to the SAXS data 
in Figure 2c data are displayed in Figure S1. Fitting parameters,   listed in Table S2, were 
used to calculate the electron density distribution across the bilayers (Figure S2). 
Results obtained from the fitting of the SAXS data describe the formation of two co-existing 
bilayers upon addition of RA3R to the sample (bilayers A and B, Table S2). SAXS fittings 
provide the distance between the lipid headgroups, lH (Table S2). The water layer thickness 
between bilayers, lw, can be estimated from the bilayer repeat distance (dA= 71.7 Å or dB= 
61.2 Å, Table 1) minus lH, according to lw,i = di- lH (i= A, B). 
Our results provide lw,A = 13.5 or 13.6 Å for 0.25 or 0.5 wt% RA3R respectively and lw,B = 
13.1, 13.2 or 13.1 Å for 0.08, 0.25 or 0.5 wt% RA3R respectively.  Parameters lw,A  and lw,B 
are similar for all samples in Table S2.  This is in contrast with lH ~ 58 Å for bilayers A 
against lH ~ 48 Å for bilayers B (Table S2).  As a whole, results in Figure S1 and Table S2 
confirm that dA and dB in Table 1 originate from two populations of lipid bilayers with different 
lH but similar lw. 
The nanostructure of the samples containing peptides, studied in Figure 2 and Table S1, 
was also investigated by cryo-TEM. Cryo-TEM images correspond to the supernatant or to 
the bulk sample, for samples presenting precipitation or for homogeneous samples 
respectively (Table S1). Following the inspection of all cryo-TEM images, it is possible to 
classify vesicles according to the three types displayed in Figure 3. The first are simple thin 
wall vesicles, which may be unilamellar vesicles (confirmed by SAXS), the second are thin 
wall vesicles with internal structure, i.e. internal compartmentalization and the third are multi-
lamellar vesicles with uncorrelated layers and typically (but not necessarily) internal 
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compartmentalization. The classification of vesicles according to Figure 3 is modified from 
that introduced in ref. 22 for POPG/POPE vesicles in the absence of peptide. Table 2 
summarizes vesicle morphologies identified by cryo-TEM. Figures S3 to Figure S8 show 
cryo-TEM images from all samples.  
A repeat distance between bilayers dcryo could be measured in some cryo-TEM 
images (e.g. inset in Figures S4b, S5a and S6b). However, dcryo, listed in Table 2, cannot be 
solely assigned to dA or dB measured by SAXS because the error in cryo-TEM 
measurements (~ 10 Å) falls within the difference between dA and dB. 
 In an attempt to understand the role of electrostatic effects on the interaction of RA3R 
with POPG/POPE vesicles, we studied the interaction of this peptide with zwitterionic 
DOPC/POPC MLVs by SAXS.  
Figure 4 shows the SAXS measured for a sample containing DOPC= 0.2 with 0, 0.8, 
0.25 and 0.5 wt% RA3R. The SAXS for samples with only DOPC= 0.2 displays two peaks in a 
positional ratio 1:2 corresponding to a lamellar spacing of 64.4 Å (Figure 4). To our 
knowledge there are no previous records in the literature for the lamellar spacing of 
POPC/DOPC MLVS. However, a lamellar repeat distance of ~ 63 Å has been reported for 
POPC MLVs at room temperature45 while lamellar spacings of 62.5 Å and 63.1 Å have been 
reported for DOPC MLVs at room temperature46 and 30 oC47 respectively. Figure 4 shows 
that gradual addition of RA3R induces the de-correlation of the lipid bilayers. 
The different effects produced in the SAXS curves by adding RA3R to POPG/POPE 
vesicles (Figure 2) or POPC/DOPC vesicles (Figure 4) can be attributed to the electrostatic 
interaction between RA3R and the lipids. 
SAXS data in Figure 4 was fitted using the same method described before to fit the SAXS 
data in Figure 2c. The fitted SAXS data is shown in Figure S9 while the parameters 
extracted from the fitting are listed in Table S3. The electron density profile of the bilayers, 
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calculated with parameters listed in Table S3 is displayed in Figure S10. The extracted 
parameters describe the de-correlation of bilayers induced upon addition of RA3R to 
DOPC=0.2 vesicles. This is denoted by the decrease in the length of correlation of the 
bilayers from N= 8 to N= 2 by adding 0.5 wt% RA3R to the zwitterionic bilayers. 
Figure 5a shows a representative cryo-TEM image for a sample only with DOPC= 0.2. 
There is co-existence of vesicles type (i), (ii) and (iii) described in Figure 3. Some of the 
vesicles show a spacing (6.2±1.3) nm at the walls, similar to the lamellar spacing 64.4 Å 
measured by SAXS for 0.5 wt% DOPC= 0.2 (Figure 4). Figure 5b shows that for DOPC= 0.2 + 
0.5 wt% RA3R, the destabilization of lipid bilayers suggested by the SAXS data in Figure 4,  
corresponds to decreased correlation of lipid bilayers in type  (iii) vesicles. The is confirmed 
by SAXS which shows a broad peak in the intensity profile, instead of Bragg reflections 
(Figure 4).  
It is likely that RA3R is adsorbed at either side of POPC/DOPC bilayers. 
Consequently, a net positive charge is added to the bilayer surface, increasing the repulsion 
between bilayers and therefore reducing their correlation length. A similar effect was 
reported to us for the interaction of the peptide A6R with zwitterionic MLVs of DPPC.16 On 
the other hand, electrostatic interactions between RA3R and POPG/POPE vesicles increase 
the correlation between lipid bilayers. In contrast to POPC and DOPC, the positively charged 
NH3+ group in POPE is exposed to water. In contrast to POPC and DOPC, the positively 
charged NH3+ group in POPE is exposed to water. In the presence of RA3R, the balance of 
the zwitterionic interaction between the phosphate group and the NH3+ group in the POPE 
may be driven towards favouring the interaction between the positively charged RA3R and 
the phosphate group of the POPE. An attractive electrostatic interaction between the RA3R 
and POPG is expected due to their opposite charges. 
The interaction between alanine-based short peptides and anionic or zwitterionic 
small unilamellar vesicles (SUVs) has been reported in a previous study.15  Similarly to 
results presented here, it was found that A9K strongly interacts with the membrane at the 
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wall of phosphatidylglycerol SUVs, causing a strong disruption of its structure, but barely 
affects the membrane of phosphatidylcholine SUVs. 
The thermal stability of lamellar phase spacings was tested through temperature 
ramp-SAXS experiments on the sample with POPG =0.4 + 0.08 wt% RA3R. Figure 6 displays 
the SAXS results where the temperature was increased from 10 to 60 oC and subsequently 
decreased to 20 oC. The spacing dA is 70.9 Å at 10 oC and 73 Å at 20 oC, disappears 
between 30 and 60 oC, but it appears again as dA= 72.3 Å when the temperature is 
decreased from 60 to 20 oC. Spacing dB gradually changes from 61.9 into 58.3 Å when the 
temperature increases from 10 to 60 oC, but it returns to dB= 63.7 Å when the temperature is 
decreased from 60 to 20 oC. Lipid bilayers with lamellar spacing dB resist temperature 
changes, while lipid bilayers with lamellar spacing dA are stable only up to 20 oC. It is likely 
that dA corresponds to lipid chains in the L (gel-solid ordered phase) conformation, which 
changes into the L (fluid disordered liquid crystal phase) conformation with spacing dB, upon 
raising the temperature. Extrapolating these results, dA and dB listed in Table 1 for samples 
containing RA3R, originate from two populations of lipid chains in the L (dA) or in the L (dB) 
phase. This hypothesis points to a phase co-existence of both phases for mixed peptide/lipid 
samples in Figure 2, with POPG > 0. 
MTT assays, using 161Br skin fibroblast cells, were performed to evaluate the 
cytocompatibility of RA3R. Viability results (Figure 7) show that the peptide was tolerated by 
the cells up to a concentration of 0.01 wt%. But above this concentration there is a steady 
decrease in cell proliferation, such that cell viability is reduced from 78% to 34% when the 
peptide concentration is increased from 0.05 to 0.5 wt%. Since RA3R does not self-assemble 
in solution, the reduction in cell viability might be triggered by the intrinsic effect of the 
cationic residues interacting with the PC lipids (cf. Figure 4).  
To study the antimicrobial activity of the RA3A peptide we selected both Gram 
negative and Gram positive microorganisms. The Gram negative bacteria was E. coli, which 
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is one of the most studied microorganisms with a variety of pathogenic strains causing a 
range of negative health problems generally resulting from foodborne contamination.48 The 
two Gram positive bacteria were S. aureus, a highly key human nosocomial and foodborne 
pathogen and L. monocytogenes which currently is one of the deadliest foodborne 
pathogens with a mortality rate of 30%.23, 49 
 Antimicrobial assays to assess the potential antimicrobial activity of RA3A, measured 
the survival of S. aureus,  E. coli, and L. monocytogenes after exposure to the presence  or 
absence of 0.25 wt% RA3R under aqueous conditions. The results are displayed in Figure 8. 
An effect of the peptide treatment in the range of 3.5 orders of magnitude reduction 
of the CFU/ml was found against E. coli (Gram negative organism) which however, was not 
statistically significant. A major effect of RA3A was found with L. monocytogenes, 
represented by a 5.6 log reduction in CFU/ml (Figure 8). A less pronounced effect in the 
range of 2.6 log reduction of the CFU/ml was found for RA3R in contact with S. aureus. The 
CFU/ml reduction effect was however statistically significant only for L. monocytogenes.  
This result is different from our previous experiments for closely related SLPs, which report 
the antimicrobial activity of 0.25 wt% A6R against S. aureus.16 
Overall, a dramatic effect of this peptide on the numbers of L. monocytogenes was 
seen within the first hours of the challenge where approximately a 4 order of magnitude 
reduction occurred within the first 2 hours. In contrast, the effect on E. coli and S. aureus 
seemed to be steadier throughout time as the logarithmic reduction within the first 2 h was 
proportional to that which occurred within 24 h.   These results suggest a strong antibacterial 
effect on Gram positive bacteria and a possibly small but potentially significant impact on 
Gram negative organisms when exposed to high contractions of this type of peptide.  
Here, antimicrobial assays are performed at 0.25 wt% RA3R because we investigate 
bacteria survival within a few minutes. The concentration 0.25wt% RA3R resulted in a 
reduction of fibroblast numbers by ~40% (Figure 7) while it caused a reduction of about 4 - 5 
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orders of magnitude in L. monocytogenes numbers (Figure 8c). Accordingly, if we started 
with 10,000 fibroblasts we would be left with 4,000 while with the same treatment we would 
be left with 1 out of 10,000 cells of L. monocytogenes. Furthermore, the effect on fibroblasts 
is after 67 hours incubation while that on Listeria is only after 1 hour. This demonstrates the 
compound is clearly highly antimicrobial.  
L. monocytogenes contains 80-85% phospholipid of the PG type and 15-20% neutral 
lipid.50 This membrane composition is intermediate to POPG = 1 and POPG = 0.6 in our work. 
We therefore argue that the antimicrobial activity of 0.25 wt% RA3R on L. monocytogenes 
(Figure 8) does not take place through membrane lysis, but through a re-organization of the 
membrane bilayers, similar to that shown in Figures 2a-b. 
The antimicrobial activity of RA3R against E. coli (Gram negative) and S. aureus 
(Gram positive) can be compared to that reported in the literature for the closely related 
peptide A3K.15 Similar to RA3R, addition of 0 to 0.02 wt% A3K to E. coli DH5a (Gram 
negative) or S. aureus (Gram positive) did not cause a great reduction in the number of 
bacteria.15 
    
Conclusions 
Our results show that RA3R does not aggregate in water, but adopts a polyproline II 
collagen-like conformation for 0.08-0.5 wt% peptide. Interaction of RA3R with model bacterial 
membranes (POPG/POPE vesicles) induces a strong correlation between the lipid bilayers. 
RA3R enhances the correlation POPG/POPE bilayers through the attractive electrostatic 
interaction with POPG together with the shift of the zwitterionic interaction in POPE towards 
an attractive electrostatic interaction with the peptide.  
The walls of RA3R/POPG/POPE vesicles with POPG > 0 present a co-existence of 
lamellar orders with cell parameters dA and dB, which span a range dA= (70.9-72.9) Å and 
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dB= (59.3-63.7) Å for POPG = 0.2-1. The cell parameters are controlled by the conformation 
of the lipid chain; dA and dB corresponding to the L and L phases respectively. This hybrid 
lamellar order can build the walls of (i) thin wall vesicles with no internal structure, (ii) 
compartmentalized thin wall vesicles or (iii) multilayer vesicles with uncorrelated layers and 
compartmentalization. In contrast, the addition of RA3R to POPC/DOPC vesicles leads to the 
de-correlation of the lipid bilayers. In this case, the zwitterionic groups of the lipids are not 
exposed to water and therefore less likely to interact with RA3R, preventing an increase in 
the bilayer correlation. 
The affinity of RA3R for POPE/POPG membranes compared to the weak interaction 
with POPC/DOPC membranes shows the ability of RA3R to distinguish between bacterial 
and mammalian cells. In fact, RA3R was tolerated by skin fibroblast cells for a concentration 
of 0.01 wt%, with cell viability highly reduced for 0.05-0.5 wt% RA3R. However, 0.25 wt% 
RA3R probed to be an efficient antibacterial agent against L. monocytogenes, setting a 
precedent to develop new formulations containing RA3R as the active agent against L. 
monocytogenes bacteria. 
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Table 1. Representative examples, as a function of  POPG, for the indexation of the SAXS 
data in Figure 2: spacings d, measured from the position of the peaks in the SAXS data (d= 
2/q0; q0= position of the peak maximum), ratios between spacings showing a lamellar order 
and lamellar cell parameter di=A,B.  
 
 
 
Table 2. Information from cryo-TEM images (representative examples Figures S3-S8): 
vesicles types indicated as (i), (ii) or (iii), according to Figure 3, and repeat bilayer distance 
dcryo.  
POPG 
 
wt% RA3R 
  
1 
 
0.6 
 
0.5 
 
0.4 
 
0.2 
 
0 
 
0.08 
Vesicle type  
dcryo [Å] 
(i) 
-- 
(i), (ii) 
-- 
(i), (ii), (iii) 
63.4±12.8 
(i), (ii), (iii) 
73.4±17.6 
(i), (ii) 
57.9±8.2 
(i), (ii), (iii) 
64.8±4.1 
 
0.25 
Vesicle type 
dcryo [Å] 
(i), (ii) 
-- 
(i), (ii), (iii) 
63.1±12.3 
(i), (ii), (iii) 
-- 
(i), (iii) 
64.3±11.1 
(i), (ii), (iii) 
-- 
(i), (iii) 
-- 
 
0.5 
Vesicle type 
dcryo [Å] 
-- 
-- 
-- 
-- 
(i), (ii) 
-- 
-- 
-- 
(i), (ii), (iii) 
52.9±7.2 
(i),  (iii) 
69±10.5 
 
 
 
 
 
 
 
 
 POPG = 1 + 
0.5 wt% RA3R 
POPG = 0.6 +  
0.25 wt% RA3R 
POPG = 0.5 +   
0.25 wt% RA3R 
POPG = 0.4 +  
0.25 wt% RA3R 
POPG = 0.2 + 
0.25 wt% RA3R 
POPG = 0 
d [Å] 
ratio 
dA [Å] 
70.9:35.6 
1:2 
70.9 
71.4:37.8:24 
1:1.8:3 
71.4 
71.7:35.9:24.1:17.9 
1:2:3:4 
71.7 
71.9:36.6:24.1:18.1 
1:2:3:4 
71.9 
72.9:36.6 
1:2 
72.9 
-- 
-- 
-- 
d [Å] 
ratio 
dB [Å] 
59.3:29.8:19.8 
1:2:3 
59.3 
60.6:30.3:20.2 
1:2:3 
60.6 
61.2:30.5:20.3 
1:2:3 
61.2 
62.2:30.9:18.1 
1:2:3 
62.2 
63.7:31.9 
1:2 
63.7 
61.6:30.9:20.6 
1:2:3 
61.6 
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Scheme 1. Chemical formulas for the lipids and peptide used in this work 
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Figure 1. (a) CD, (b) FTIR, (c) SAXS data for RA3R solutions. The full line in (c) corresponds 
to the fitting of the experimental data. The intensity of the FTIR spectra for 2 wt% RA3R has 
been divided by 2, and the SAXS data for 0.5 wt% has been multiplied by an arbitrary factor 
in order to aid visualisation. 
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Figure 2. SAXS data for samples displayed in Table S1. The SAXS curves have been 
multiplied by an arbitrary factor in order to aid visualisation. Spacings d= 2/q0 (q0: position 
of the peak maximum) were calculated using the reflexions indicated as 1-7. 
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Figure 3. Classification of vesicle types. Top row: (i) Thin wall vesicles with no internal 
structure, (ii) Compartmentalized thin wall vesicles, (iii), multilayer vesicles with uncorrelated 
layers and compartmentalization.  Bottom row: Typical cryo-TEM images for the three types 
(i) POPG=0.2 + 0.08 wt% RA3R  (ii)  POPG=0.6 + 0.08 wt% RA3R, (iii) POPG=0.2 + 0.5 wt% 
RA3R. 
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Figure 4. SAXS results obtained for samples with DOPC= 0.2 + 0.08, 0.25 or 0.5 wt% RA3R. 
The SAXS curves have been multiplied by an arbitrary factor in order to aid visualisation. 
Spacings d= 2/q0 (q0: position of the peak maximum) were calculated using the reflexions 
indicated as 1-2. 
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Figure 5. Cryo-TEM images recorded for DOPC = 0.2 + (a) 0 or (b) 0.5 wt% RA3R.  
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Figure 6. SAXS intensity profiles obtained for POPG= 0.4 + 0.08 wt% RA3R, display the 
temperature dependence of the reflexions in Figure 2d. 
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Figure 7. Cell viability of RA3R solutions. Error bars: SEM (n = 3). All concentrations show 
statistical significance from the mean, p<0.001.  
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Figure 8. Survival of (a) S. aureus, (b) E. coli, and (c) L. monocytogenes after exposure to 
the presence (orange dash lines) or absence of 0.25 wt% RA3R under aqueous conditions 
(blue full lines). (d) Data plotted in (a-c): E. coli (boxes), L. monocytogenes (circles), S. 
aureus (triangles). Estimations of the cell numbers (CFU: colony-forming units) at each time 
point were performed in triplicate (3 biological replicates) while each dilution was plated in 
duplicate (2 technical replicates). Markers represent an average of the measurements 
performed in triplicate, and error bars represent the standard deviation. Asterisks denote 
statistically significant difference between the treated and untreated strain at the specific 
time point as assessed by a t-test (P<0.05). 
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